- Report
- January 2025
- 132 Pages
Global
From €901EUR$950USD£758GBP
- Report
- January 2025
- 132 Pages
Global
From €901EUR$950USD£758GBP
- Report
- July 2024
- 132 Pages
Global
From €901EUR$950USD£758GBP
- Report
- March 2024
- 132 Pages
Global
From €901EUR$950USD£758GBP
- Report
- January 2025
- 132 Pages
Global
From €901EUR$950USD£758GBP
From €122EUR$129USD£103GBP
- Report
- November 2021
- 527 Pages
Global
From €3795EUR$4,000USD£3,190GBP
- Report
- November 2021
- 365 Pages
Global
From €3320EUR$3,500USD£2,792GBP
- Report
- November 2021
- 1184 Pages
Global
From €5692EUR$6,000USD£4,786GBP
- Report
- November 2021
- 802 Pages
Global
From €4743EUR$5,000USD£3,988GBP
- Report
- November 2021
- 1165 Pages
Global
From €5692EUR$6,000USD£4,786GBP
- Report
- December 2022
- 229 Pages
Global
From €3387EUR$3,570USD£2,847GBP
- Report
- March 2022
- 257 Pages
Global
From €3521EUR$3,712USD£2,961GBP
- Report
- December 2023
- 219 Pages
Global
From €3387EUR$3,570USD£2,847GBP
- Report
- December 2024
- 321 Pages
Global
From €2519EUR$2,655USD£2,118GBP
- Report
- July 2024
- 280 Pages
Global
From €2519EUR$2,655USD£2,118GBP
- Report
- June 2023
- 266 Pages
Global
From €3387EUR$3,570USD£2,847GBP

Cell therapy is a type of biotechnology that involves the use of living cells to treat or prevent a disease. It is a rapidly growing field of medicine that has the potential to revolutionize the way diseases are treated. Cell therapy involves the use of living cells, either from the patient or from a donor, to replace or repair damaged cells or tissues. This can be done through the use of stem cells, gene therapy, or other cell-based therapies. Cell therapy has the potential to treat a wide range of diseases, including cancer, heart disease, diabetes, and neurological disorders.
Cell therapy is a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Novartis, Celgene, and Kite Pharma are leading the way in developing cell therapies for a variety of diseases. Other companies such as Gilead Sciences, Juno Therapeutics, and Bluebird Bio are also investing in cell therapy research and development. These companies are working to develop treatments that can improve the quality of life for patients with a variety of diseases. Show Less Read more